Guest Dr Rakhi Maiwall (Delhi India) ×
Acute on chronic liver failure 1
Theme Decoding ACLF: Definitions, Debates & Extracorporeal Therapies
Date & Time 21st Nov Friday 11:52 - 12:02 Hrs
Location Hall A
Role Speaker
Genre Talk (Evidence-based review)
Topic

Extra-corporeal therapies for ACLF: Do they really improve survival?
Transplant Infectious Disease - 2
Theme Unravelling the prophylactic intricacies in Immunosuppressed
Date & Time 22nd Nov Saturday 11:10 - 11:35 Hrs
Location Hall A
Role Moderator
Topic

Case based Panel Discussion: Alcoholic ACLF presenting with MELD 37 (after initial admission in local unit), proc al 2.5, blood c/s- no growth and TLC 20000/mm3, planned for an ABOi Liver Transplantation

Sub-topics: 

1. How should the elevated TLC be interpreted in the context of ACLF? Is it indicative of an infection not detected by blood culture, or could it be related to the severe inflammation associated with ACLF?

2. In ALF we start prophylactic antibiotics and anti-fungal: Does same holds true for ACLF, High MELD

3. What role do other inflammatory markers (e.g., CRP, procalcitonin) play in guiding management decisions in this patient? Practice in Panelists unit